Interplay of virulence factors shapes ecology and treatment outcomes in polymicrobial infections

C Herzberg1, E N van Meegen1, J G C van Hasselt1

  • 1Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333CC Leiden, The Netherlands.

Mathematical Biosciences
|September 8, 2024
PubMed

Insights

Polymicrobial infections (PMIs) involve complex bacterial interactions. Targeting bacterial virulence factors, which influence immune responses, can improve treatment outcomes for these severe infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Computational Biology

Background:

  • Polymicrobial infections (PMIs) are caused by multiple microorganisms and are linked to increased disease severity and worse patient outcomes.
  • Understanding the ecological and evolutionary dynamics of PMIs is crucial for developing effective antimicrobial strategies.
  • Bacterial virulence factors can modulate host immune responses, influencing interspecies interactions within PMIs.

Purpose of the Study:

  • To investigate how bacterial virulence factors targeting neutrophil function impact the ecology and treatment outcomes of PMIs.
  • To model the interplay between bacterial species, host immune cells (neutrophils), and antimicrobial drugs in a polymicrobial setting.

Main Methods:

  • Construction of an agent-based model simulating a dual-species bacterial population interacting with neutrophils and a bacteriostatic drug.
  • Analysis of the dynamics arising from the interaction of multiple virulence factors, including those inhibiting phagocytosis and neutrophil recruitment.
  • Evaluation of the impact of virulence factor distribution and relative virulence strength on species survival and population dynamics.

Main Results:

  • Virulence factors mediating interspecies interactions can lead to unforeseen ecological dynamics.
  • The distribution of phagocytosis-inhibiting virulence factors influences whether bacterial species offer mutual protection.
  • Inhibiting neutrophil recruitment can diminish the protective effects conferred by phagocytosis-inhibiting factors.
  • The relative virulence strength of a species is critical in determining its persistence within the polymicrobial community.

Conclusions:

  • Bacterial virulence factors are significant drivers of population dynamics in polymicrobial infections.
  • Targeting virulence factors represents a potential therapeutic strategy for treating PMIs.
  • Modulating host-mediated interspecies interactions through virulence factor manipulation may offer new treatment avenues.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
950
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.8K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.3K